Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Molina Healthcare, Inc. securities between February 5, 2025, and July 23, 2025, due to undisclosed adverse facts affecting the company's financial guidance and operations [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Molina Healthcare failed to disclose material adverse facts regarding its medical cost trend assumptions and the dislocation between premium rates and medical costs [5]. - The lawsuit alleges that Molina's near-term growth relied on a lack of utilization of various health services, which was not communicated to investors [5]. - As a result of these undisclosed facts, Molina's financial guidance for fiscal year 2025 was likely to be cut, leading to misleading positive statements about the company's business and prospects [5]. Group 2: Participation Information - Investors who purchased Molina securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, investors can visit the provided link or contact the law firm directly for more information [3][6]. - A lead plaintiff must move the Court by December 2, 2025, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and recognition in the field [4]. - The firm has recovered hundreds of millions of dollars for investors, with notable achievements in 2019 and 2020 [4]. - Investors are encouraged to select qualified counsel with a proven success record, as many firms may lack comparable experience [4].

Core Viewpoint - Molina Healthcare, Inc. is facing a class action lawsuit for alleged violations of the Securities Exchange Act of 1934, with claims that the company and its executives failed to disclose critical financial information during the class period from February 5, 2025, to July 23, 2025 [1][3]. Group 1: Allegations and Financial Impact - The lawsuit alleges that Molina Healthcare did not disclose adverse facts regarding its medical cost trend assumptions and the dislocation between premium rates and medical costs [3]. - It is claimed that Molina's near-term growth relied on low utilization of various healthcare services, which was not communicated to investors [3]. - Following the announcement of second quarter 2025 adjusted earnings of approximately $5.50 per share, which was below expectations due to medical cost pressures, Molina cut its earnings guidance by 10.2% at the midpoint [4]. - On July 23, 2025, Molina reported a GAAP net income of $4.75 per diluted share for the second quarter, an 8% decrease year-over-year, and revised its full-year 2025 adjusted earnings expectation to no less than $19.00 per diluted share [5]. Group 2: Class Action Process - Investors who purchased Molina Healthcare securities during the class period can seek appointment as lead plaintiff in the class action lawsuit, which allows them to act on behalf of other class members [6]. - The lead plaintiff can select a law firm of their choice to represent the class in the lawsuit [6]. Group 3: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [7]. - The firm has been recognized for securing the most monetary relief for investors in securities class action cases, ranking 1 in the ISS Securities Class Action Services rankings for four out of the last five years [7].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Molina Healthcare, Inc. due to alleged violations of federal securities laws, particularly concerning misleading statements about the company's financial health and medical cost trends [3][4]. Summary by Sections Company Overview - Molina Healthcare, Inc. is a publicly traded company on the NYSE under the ticker MOH [1]. Allegations - The complaint alleges that Molina and its executives made false or misleading statements regarding: - Material adverse facts about the company's medical cost trend assumptions [3]. - A dislocation between premium rates and medical costs [3]. - Dependency on low utilization of behavioral health and other services for near-term growth [3]. - Likelihood of substantial cuts to financial guidance for fiscal year 2025 [3]. - Misleading positive statements about the company's business and operations [3]. Financial Performance - On July 7, 2025, Molina announced second-quarter results, reporting adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures [4]. - The company cut its full-year 2025 adjusted earnings guidance by 10.2%, revising it from at least $24.50 per share to a range of $21.50 to $22.50 per share [4]. - Following this announcement, Molina's stock price fell by $6.97, or 2.9%, closing at $232.61 per share [4]. Further Guidance Cuts - On July 23, 2025, Molina further reduced its full-year 2025 earnings guidance, expecting adjusted earnings to be no less than $19.00 per diluted share, representing a 13.6% cut from previous guidance [5]. - The company also cut its full-year GAAP net income guidance by 27% to $912 million [5]. - Following this news, Molina's stock price dropped by $32.03, or 16.84%, closing at $158.22 per share [5].

, /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Molina Healthcare, Inc. ("Molina " or "the Company") (NYSE: MOH ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of MOH during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not requ ...

NEW YORK, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.  The class action concerns whether Molina and certain of its ...

Core Insights - Molina Healthcare (NYSE: MOH) is a significant entity in the healthcare sector, providing managed health care services under Medicaid and Medicare programs, and competes with major players like UnitedHealth Group and Centene Corporation [1] Stock Performance - Truist Financial has set a new price target for Molina Healthcare at $210, suggesting an 8.04% potential increase from its current trading price of $194.37, which has slightly decreased by 0.14% [2][6] - The stock has experienced volatility, with a market capitalization of approximately $10.5 billion, and has fluctuated between a low of $191.70 and a high of $194.72 on the current trading day [4][6] Legal Issues - A lawsuit has been filed against Molina Healthcare and certain senior executives for potential violations of federal securities laws, with a court deadline set for December 2, which may impact stock performance [3][6] - The ongoing legal challenges have led to increased investor interest, as reflected in the trading volume of 120,459 shares on the NYSE [5]

Core Viewpoint - A lawsuit has been filed against Molina Healthcare, Inc. and certain senior executives for potential violations of federal securities laws, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [1][2]. Group 1: Lawsuit Details - Investors have until December 2, 2025, to request to lead the case, which is pending in the U.S. District Court for the Central District of California [2]. - The lawsuit is titled Hindlemann v. Molina Healthcare, Inc., et al., No. 25-cv-9461 [2]. Group 2: Company Background - Molina Healthcare is a health insurance company that provides managed healthcare services to low-income individuals under Medicaid and Medicare programs [3]. - The company previously claimed a "solid" earnings growth profile heading into 2025 and stated it was able to mitigate healthcare cost inflation [3]. Group 3: Financial Performance and Stock Impact - On July 7, 2025, Molina reported Q2 2025 adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines [4]. - The company cut its guidance for expected adjusted earnings per share by 10.2%, revising it to a range of $21.50 to $22.50 per share [4]. - On July 23, 2025, Molina adjusted its full-year 2025 earnings expectation to no less than $19.00 per diluted share, citing a challenging medical cost trend environment [4]. - Following this announcement, Molina's stock price fell by $32.03 per share, or 16.8%, from $190.25 to $158.22 [4].

, /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Molina Healthcare, Inc. ("Molina" or the "Company") (NYSE: MOH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The class action concerns whether Molina and certain of its officers and/or directors ha ...

Core Viewpoint - The Molina Healthcare class action lawsuit alleges that the company and its executives violated the Securities Exchange Act of 1934 by failing to disclose critical adverse information regarding its financial health and operational challenges during the specified class period [1][4]. Group 1: Class Action Details - The class action lawsuit is titled Hindlemann v. Molina Healthcare, Inc., and covers purchasers of Molina Healthcare securities from February 5, 2025, to July 23, 2025, with a deadline of December 2, 2025, for seeking lead plaintiff status [1]. - The lawsuit claims that Molina Healthcare did not disclose material facts about its medical cost trend assumptions and the dislocation between premium rates and medical costs [4]. Group 2: Financial Performance and Impact - On July 7, 2025, Molina Healthcare reported adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines, leading to a 10.2% cut in earnings guidance [5]. - Following the financial results announcement on July 23, 2025, Molina Healthcare reported a GAAP net income of $4.75 per diluted share for Q2 2025, an 8% decrease year-over-year, and revised its full-year 2025 adjusted earnings guidance to no less than $19.00 per diluted share [6]. Group 3: Legal Process and Representation - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Molina Healthcare securities during the class period to seek lead plaintiff status, which involves directing the class action lawsuit on behalf of all class members [7]. - Investors are not required to serve as lead plaintiff to share in any potential recovery from the lawsuit [7]. Group 4: Company Overview - Molina Healthcare provides managed healthcare services primarily to low-income families and individuals under Medicaid and Medicare programs [3].

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of Molina Healthcare, Inc. securities, alleging that the company failed to disclose material adverse facts during the Class Period from February 5, 2025, to July 23, 2025 [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Molina Healthcare did not disclose critical information regarding its medical cost trend assumptions and the dislocation between premium rates and medical costs [5]. - The lawsuit alleges that Molina's near-term growth relied on a lack of utilization of various health services, which was not communicated to investors [5]. - As a result of these undisclosed facts, Molina's financial guidance for fiscal year 2025 was likely to be significantly reduced, misleading investors about the company's business prospects [5]. Group 2: Participation Information - Investors who purchased Molina securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm directly for more information [3][6]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has consistently ranked highly in terms of the number of securities class action settlements and has recovered hundreds of millions of dollars for investors [4].